Pathophysiological remodeling of mouse cardiac myocytes expressing dominant negative mutant of neuron restrictive silencing factor

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2712-2719

  Takano, Makoto ^a   Kinoshita, Hideyuki ^b   Shioya, Takao ^c   Itoh, Masayuki ^a   Nakao, Kazuwa ^b   Kuwahara, Koichiro ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

Arrhythmia; Cardiac myocytes; Hypertrophy; REST NRSF

Indexed keywords

2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; CALCIUM ION; ION CHANNEL; NEURON RESTRICTIVE SILENCING FACTOR; SODIUM ION; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CATION EXCHANGE; CELL DENSITY; CELL ISOLATION; CELL KINETICS; CELL MEMBRANE DEPOLARIZATION; CELL MUTANT; CONTROLLED STUDY; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; ION PERMEABILITY; MEMBRANE CURRENT; MOUSE; NONHUMAN; PATCH CLAMP; PATHOPHYSIOLOGY; POTASSIUM CURRENT; REDUCTION KINETICS; WHOLE CELL;

ACTION POTENTIALS; ANILINE COMPOUNDS; ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; HEART VENTRICLES; MICE; MICE, MUTANT STRAINS; MUTATION; MYOCYTES, CARDIAC; PHENYL ETHERS; POTASSIUM; REPRESSOR PROTEINS; SODIUM-CALCIUM EXCHANGER;

EID: 78649711769     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0652     Document Type: Article

References (24)

1. Nattel S, Khairy P, Schram G. Arrhythmogenic ionic remodeling: Adaptive response with maladaptive consequences. Trends Cardiovasc Med 2001; 11: 295-301.
2. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004; 95: 754-763.
3. Pogwizd SM, Bers DM. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 2004; 14: 61-66.
4. Koyama T, Ono K, Watanabe H, Ohba T, Murakami M, Iino K, et al. Molecular and electrical remodeling of L- and T-type Ca2+ channels in rat atrium with monocrotaline-induced pulmonary hypertension. Circ J 2009; 73: 256-263.
5. Kuwahara K, Saito Y, Ogawa E, Takahashi N, Nakagawa Y, Naruse Y, et al. The neuron-restrictive silencer element-neuronrestrictive silencer factor system regulates basal and endothelin 1- inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol Cell Biol 2001; 21: 2085-2097.
6. Kuratomi S, Kuratomi A, Kuwabara K, Ishii TM, Nakao K, Saito Y, et al. NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes. Biochem Biophys Res Commun 2007; 353: 67-73.
7. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y, et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 2003; 22: 6310-6321.
8. Ohba T, Watanabe H, Takahashi Y, Suzuki T, Miyoshi I, Nakayama S, et al. Regulatory role of neuron-restrictive silencing factor in expression of TRPC1. Biochem Biophys Res Commun 2006; 351: 764-770.
9. Watanabe H, Murakami M, Ohba T, Ono K, Ito H. The pathological role of transient receptor potential channels in heart disease. Circ J 2009; 73: 419-427.
10. Kinoshita H, Kuwahara K, Takano M, Arai Y, Kuwabara Y, Yasuno S, et al. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Circulation 2009; 120: 743-752.
11. Shioya T. A simple technique for isolating healthy heart cells from mouse models. J Physiol Sci 2007; 57: 327-335.
12. Tanaka H, Namekawa I, Takeda K, Kazama A, Shimizu Y, Moriwaki R, et al. Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchanger. Naunyn-Schmiederbers's Arch Pharmacol 2005; 371: 526-534.
13. Nagy ZA, Toth A, Biliczki P, Acsai K, Banyasz T, Nanasi P, et al. Selective inhibition of sodium-calcium exchanger by SEA0400 decreases early and delayed after depolarization in canine heart. Br J Pharmacol 2004; 143: 827-831.
14. Odening KE, Nerbonne JM, Bode C, Zehender M, Brunner M. In vivo effect of a dominant negative Kv4.2 loss-of-function mutation eliminating Ito,f on atrial refratoriness and atrial fibrillation in mice. Circ J 2009; 73: 461-467.
15. Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR, et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol 2005; 38: 475-483.
16. Eckhardt LL, Teelin TC, January CT. Is ranolazine an antiarrhythmic drug? Am J Physiol 2008; 294: H1989-H1991.
17. Eisner DA, Kshimura T, Venetucci LA, Trafford AW. From the ryanodine receptor to cardiac arrhythmias. Circ J 2009; 73: 1561-1567.
18. Nakagawa Y, Kuwahara K, Harada M, Takahashi N, Yasuno S, Adachi Y, et al. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J Mol Cell Cardiol 2006; 41: 1010-1022.
19. Fauconnier J, Lacampagne A, Rauzier JM, Vassort G, Richard S. Ca2+-dependent reduction of IK1 in rat ventricular cells: A novel paradigm for arrhythmia in heart failure? Cardiovasc Res 2005; 68: 204-212.
20. Xie LH, Chen F, Karaguenzian HS, Weiss JN. Oxidative stress induced afterdepolarizations and calmodulin kinase II signaling. Circ Res 2008; 104: 79-86.
21. Bers DM, Despa S. Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts. J Pharmacol Sci 2006; 100: 315-322.
22. Cho HS, Takano M, Noma A. The electrophysiological properties of spontaneously beating pacemaker cells isolated from mouse sinoatrial node. J Physiol 2003; 550: 169-180.
23. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat Rev Mol Cell Biol 2006; 7: 589-600.
24. Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ, et al. The CaV3.2 T-type Ca2+ channel is required for pressure overload- induced cardiac hypertrophy in mice. Circ Res 2009; 104: 522-530.